Wilbanks Smith & Thomas Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,222
Closed -$90K 506
2021
Q4
$90K Hold
10,222
﹤0.01% 504
2021
Q3
$106K Buy
+10,222
New +$89.3K ﹤0.01% 493

Other funds holding SRTA

Wilbanks Smith & Thomas Asset Management's SRTA Position: Q1 2022 in Review

Wilbanks Smith & Thomas Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2022, closing a stake of 10,222 shares — an estimated $90K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in SRTA in Q3 2021 and held it in 2 quarters. The position peaked at $106K in Q3 2021. 78 funds tracked by Wall St. Rank hold SRTA as of Q1 2022.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Strata Critical Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 10,222 Strata Critical Medical Inc shares in Q1 2022, an estimated $90K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Strata Critical Medical Inc in Q3 2021 and held it in 2 quarters.
  • Wilbanks Smith & Thomas Asset Management's Strata Critical Medical Inc position peaked at $106K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2022.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2022, filed 5 May 2022.